Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ishita Drugs And IndustriesBOM:524400 -3.42%72 Days Inventory is 36.97 as of Mar. 2026, which is 15% below its 10-year median of 43.67. GuruFocus rates BOM:524400 with a GF Score™ of 72/100 and a GF Value™ of ₹78.63 (Fairly Valued). The stock has 3 warning signs investors should review. Among 921 Drug Manufacturers companies, Ishita Drugs And Industries ranks better than 85.34% on this metric.
The historical rank and industry rank for Ishita Drugs And Industries's Days Inventory or its related term are showing as below:
BOM:524400'
s Days Inventory Range Over the Past 10 Years
Min: 19.92 Med: 43.67 Max: 95.35
Current: 82.99
During the past 13 years, Ishita Drugs And Industries's highest Days Inventory was 95.35. The lowest was 19.92. And the median was 43.67.
BOM:524400's Days Inventory is ranked better than 85.34% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.24
vs BOM:524400: 82.99
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ishita Drugs And Industries's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ishita Drugs And Industries's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.30.
Ishita Drugs And Industries (BOM:524400) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ishita Drugs And Industries's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ishita Drugs And Industries's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ishita Drugs And Industries Days Inventory Related Terms
Ishita Drugs And Industries Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ishita Drugs And Industries Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ishita Drugs And Industries's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ishita Drugs And Industries (BOM:524400) has a Days Inventory of 36.97 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ishita Drugs And Industries and its competitors. This is 15% below median its historical median of 43.67. Over the past decade, Ishita Drugs And Industries' Days Inventory has ranged from 19.92 to 95.35. According to the industry distribution chart, Ishita Drugs And Industries ranks #135 out of 921 companies in the Drug Manufacturers industry, placing it in the top 14.7%.
Is Ishita Drugs And Industries' Days Inventory too high?
Ishita Drugs And Industries' current Days Inventory of 36.97 is 15% below median its 10-year median of 43.67. Over the past 10 years, this metric has ranged from a low of 19.92 to a high of 95.35. The Drug Manufacturers industry median Days Inventory is 165.24. Ishita Drugs And Industries' value of 36.97 is 77.6% below this industry median. Based on the distribution chart, Ishita Drugs And Industries ranks #135 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ishita Drugs And Industries has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ishita Drugs And Industries ranks #135 out of 921 companies for Days Inventory. This places Ishita Drugs And Industries in the top 15% of its industry — outperforming the majority of peers. The industry median Days Inventory is 165.24. Ishita Drugs And Industries' value of 36.97 is 77.6% below this benchmark. Historically, Ishita Drugs And Industries' own Days Inventory has ranged from 19.92 to 95.35 over the past decade. While the company's 10-year median is 43.67 vs. the industry median of 165.24, Ishita Drugs And Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.24, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ishita Drugs And Industries's current Days Inventory of 36.97 is 77.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ishita Drugs And Industries and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ishita Drugs And Industries's current Days Inventory is 36.97, which is 15% below median its own 10-year median of 43.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.63, compared to a current price of ₹74.37 — trading 5.4% below its estimated fair value. The current Days Inventory is 36.97, which is 15% below median its 10-year median of 43.67 and 77.6% below the Drug Manufacturers industry median of 165.24. Ishita Drugs And Industries' overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current Days Inventory is 36.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?
Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued.
The current stock price of ₹74.37 is trading 5.4% below its estimated GF Value™ of ₹78.63.
GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.
Key valuation signals for BOM:524400:
Days Inventory: 36.97 (15% below median its 10-year median of 43.67)
GF Value™: ₹78.63 vs. price of ₹74.37 (5.4% below fair value)
Industry Position: 77.6% below the Drug Manufacturers median (#135 of 921)
No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
72GF Score
Get the complete analysis for BOM:524400
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524400 has been successfully added to your 
